Fumihiko Yasuno
Obu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer's disease: A pilot study.
Journal: Brain, behavior, & immunity - health
Published: May 28, 2026
CCN1/Cyr61 associates with β-amyloid levels in human cerebrospinal fluids.
Journal: iScience
Published: November 13, 2025
Frontostriatal volumes and anterior thalamic mediation of late-life depressive symptoms across the cognitive spectrum from normal aging to Alzheimer's disease: A structural equation modelling study.
Journal: International psychogeriatrics
Published: October 04, 2025
Shift From Benzodiazepine Receptor Agonists to Orexin Receptor Antagonists and Melatonin Receptor Agonists in Alzheimer's Disease: A Multicentre Retrospective Study, Japan, 2016-2022.
Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
Published: June 11, 2025
Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer's Disease.
Journal: Neuroimmunomodulation
Published: May 07, 2025
Mediators of the Association Between Severity of Noncommunicable Diseases and Subjective Health-Related Quality of Life.
Journal: Neuropsychopharmacology reports
Published: February 13, 2025
Leptin and inflammatory pathways in the Alzheimer's disease continuum: Implications for glial activation and neuropsychiatric symptoms.
Journal: Brain, behavior, & immunity - health
Published: December 13, 2024
First-in-Human Study of [11C]NCGG401 for Imaging Colony-Stimulating Factor 1 Receptors in the Brain.
First-in-Human Study of [11C]NCGG401 for Imaging Colony-Stimulating Factor 1 Receptors in the Brain.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 28, 2024
Trait-anxiety and glial-related neuroinflammation of the amygdala and its associated regions in Alzheimer's disease: A significant correlation.
Journal: Brain, behavior, & immunity - health
Published: February 24, 2024
Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial.
Journal: JAMA network open
Published: December 04, 2023
Neuroimaging biomarkers of glial activation for predicting the annual cognitive function decline in patients with Alzheimer's disease.
Journal: Brain, behavior, and immunity
Published: April 13, 2023
Last Updated: 09/26/2026